排序方式: 共有59条查询结果,搜索用时 31 毫秒
1.
Larisa Daniela Sandulescu Cristiana Marinela Urhut Sarmis Marian Sandulescu Ana-Maria Ciurea Sergiu Marian Cazacu Sevastita Iordache 《World journal of hepatology》2021,13(12):1892-1908
Hepatic hemangioma is usually detected on a routine ultrasound examination because of silent clinical behaviour. The typical ultrasound appearance of hemangioma is easily recognizable and quickly guides the diagnosis without the need for further investigation. But there is also an entire spectrum of atypical and uncommon ultrasound features and our review comes to detail these particular aspects. An atypical aspect in standard ultrasound leads to the continuation of explorations with an imaging investigation with contrast substance [ultrasound/ computed tomography/or magnetic resonance imaging (MRI)]. For a clinician who practices ultrasound and has an ultrasound system in the room, the easiest, fastest, non-invasive and cost-effective method is contrast enhanced ultrasound (CEUS). Approximately 85% of patients are correctly diagnosed with this method and the patient has the correct diagnosis in about 30 min without fear of malignancy and without waiting for a computer tomography (CT)/MRI appointment. In less than 15% of patients CEUS does not provide a conclusive appearance; thus, CT scan or MRI becomes mandatory and liver biopsy is rarely required. The aim of this updated review is to synthesize the typical and atypical ultrasound aspects of hepatic hemangioma in the adult patient and to propose a fast, non-invasive and cost-effective clinical-ultrasound algorithm for the diagnosis of hepatic hemangioma. 相似文献
2.
3.
Randomized Multicentric Italian Study on two Treatment Regimens for Marrow Relapse in Childhood Acute Lymphoblastic Leukemia 总被引:1,自引:0,他引:1
Mario Renato Rossi Giuseppe Masera Maria Grazia Zurlo Sergio Amadori Grazia Zurlo Serenella Bagnulo Modesto Carli Luigi Zanesco Giorgio Dini Carlo Guazzelli Alessandro Rosi Enrico Madon Luigi Nespoli Guido Paolucci Andreaa Pession Paolo Tamaro 《Pediatric hematology and oncology》1986,3(1):1-9
This paper reports the results of a multicentric randomized clinical trial on the treatment of first hematological relapse in childhood ALL. Induction treatment consisted of vincristine, adriamycin, L-asparaginase, and prednisone. Patients achieving complete remission were randomized to two maintenance regimens (A and B). Regimen A consisted of five different drug associations including VM26 and IDMTX in a sequential schedule; Regimen B was essentially classical Spiers schedule for the first year, followed by a milder treatment. Eighty-four of 102 evaluahle patients (82%) achieved second complete remission. The two maintenance regimens were similar as regards duration of second complete remission (median duration A, 32 weeks; B, 37 weeks) and toxicity. Better results were obtained in patients relapsing after 12 months from suspension of treatment in first complete remission than in those relapsing within the first year off therapy (82.8% vs. 31.4%). In group A fewer CNS relapses were reported. The two regimens produced results similar to those reported by other authors. The good prognosis in patients relapsing at least 1 year after treatment suspension in first complete remission must be emphasized. 相似文献
4.
5.
A. Ginès G. Fernández-Esparrach M. Pellisé T. Pérez-Corona A. Mata J. Llach J. M. Bordas M. Sánchez M. Pages G. Martinez M. A. López-Boado A. Membrillo C. Ayuso L. Fernández-Cruz G. Durivage B. Pujol B. Napoléon V. Hervieu M. Labadie V. Napolitano G. Russo G. Rossetti L. Brusciano C. Sagnelli Donatella Pacchioni M. Bosco Grazia Accinelli Francesca Curri C. De Angelis G. Bussolati Rodica Gincoul Ines Modolell Christine Lefort J. Y. Scoazec J. C. Souquet J. A. Chayvialle A. Săftoiu S. Cazacu Carmen Popescu T. Ciurea 《Acta endoscopica》2005,35(1):59-64
6.
7.
8.
9.
Olivier Capitain Andreaa Asevoaia Michele Boisdron-Celle Anne-Lise Poirier Alain Morel Erick Gamelin 《Clinical colorectal cancer》2012,11(4):263-267
BackgroundTo compare the efficacy and safety of pharmacokinetically (PK) guided fluorouracil (5-FU) dose adjustment vs. standard body-surface-area (BSA) dosing in a FOLFOX (folinic acid, fluorouracil, oxaliplatin) regimen in metastatic colorectal cancer (mCRC).Patients And MethodsA total of 118 patients with mCRC were administered individually determined PK-adjusted 5-FU in first-line FOLFOX chemotherapy. The comparison arm consisted of 39 patients, and these patients were also treated with FOLFOX with 5-FU by BSA. For the PK-adjusted arm 5-FU was monitored during infusion, and the dose for the next cycle was based on a dose-adjustment chart to achieve a therapeutic area under curve range (5-FUODPM Protocol).ResultsThe objective response rate was 69.7% in the PK-adjusted arm, and median overall survival and median progression-free survival were 28 and 16 months, respectively. In the traditional patients who received BSA dosage, objective response rate was 46%, and overall survival and progression-free survival were 22 and 10 months, respectively. Grade 3/4 toxicity was 1.7% for diarrhea, 0.8% for mucositis, and 18% for neutropenia in the dose-monitored group; they were 12%, 15%, and 25%, respectively, in the BSA group.ConclusionsEfficacy and tolerability of PK-adjusted FOLFOX dosing was much higher than traditional BSA dosing in agreement with previous reports for 5-FU monotherapy PK-adjusted dosing. Analysis of these results suggests that PK-guided 5-FU therapy offers added value to combination therapy for mCRC. 相似文献
10.
Color and power Doppler ultrasound are useful methods for the assessment of patients with gastrointestinal diseases. The aim of our study was to assess color Doppler and power Doppler ultrasound, during the evolution of patients with ulcerative colitis and Crohn's disease treated with salazopyrin. We included in the study 10 patients with inflammatory bowel diseases diagnosed by colonoscopy with multiple biopsies. All the patients underwent color and power Doppler ultrasound using Jeffrey criteria for the evaluation of intestinal vasculature. Biological examinations included: erythrocyte sedimentation rate, serum C reactive protein, blood cell count, fibrinogenemia, protein electrophoresis and immunoelectrophoresis. The results of our study indicated a diminished blood flow at the level of the affected intestinal segments after one month of salazopyrin treatment. Color and power Doppler ultrasound might thus represent a useful method for monitoring the response in inflammatory bowel disease treatment. 相似文献